Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Carotid Atherosclerosis in Psoriatic Arthritis
NCT05988684Phase 4Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Aug 2023
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of metformin in atherosclerosis, sponsored by The Chinese University of Hong Kong. Started Aug 2023; status: completed.
02
Drugs
metformin
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT05988684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05988684.